Michael A. Veronin

659 total citations
42 papers, 405 citations indexed

About

Michael A. Veronin is a scholar working on Public Health, Environmental and Occupational Health, Anesthesiology and Pain Medicine and Geriatrics and Gerontology. According to data from OpenAlex, Michael A. Veronin has authored 42 papers receiving a total of 405 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Public Health, Environmental and Occupational Health, 10 papers in Anesthesiology and Pain Medicine and 9 papers in Geriatrics and Gerontology. Recurrent topics in Michael A. Veronin's work include Pharmaceutical Practices and Patient Outcomes (9 papers), Pain Management and Opioid Use (8 papers) and Pharmaceutical Quality and Counterfeiting (7 papers). Michael A. Veronin is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (9 papers), Pain Management and Opioid Use (8 papers) and Pharmaceutical Quality and Counterfeiting (7 papers). Michael A. Veronin collaborates with scholars based in United States, Germany and Spain. Michael A. Veronin's co-authors include Rohit Dixit, Robert P. Schumaker, Bi‐Botti C. Youan, Mohammad T. H. Nutan, Gilbert Ramı́rez, E. Neil Lewis, Eunah Lee, Sami Nazzal, Turki Al Hagbani and I. R. Daniels and has published in prestigious journals such as Science, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Michael A. Veronin

38 papers receiving 380 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael A. Veronin United States 14 106 63 55 49 32 42 405
András Fittler Hungary 12 221 2.1× 129 2.0× 42 0.8× 34 0.7× 19 0.6× 35 460
Amit Garg India 11 39 0.4× 36 0.6× 45 0.8× 10 0.2× 36 1.1× 26 490
Siti Maisharah Sheikh Ghadzi Malaysia 9 25 0.2× 47 0.7× 31 0.6× 12 0.2× 26 0.8× 46 526
Marie A. Abate United States 17 357 3.4× 22 0.3× 130 2.4× 37 0.8× 133 4.2× 55 831
Hana Sulieman United Arab Emirates 14 50 0.5× 42 0.7× 94 1.7× 45 0.9× 137 4.3× 39 555
Min Tan China 13 57 0.5× 54 0.9× 117 2.1× 34 0.7× 9 0.3× 43 692
Feliciano Yu United States 14 102 1.0× 74 1.2× 154 2.8× 29 0.6× 33 1.0× 36 702
Dennis B. Worthen United States 8 23 0.2× 37 0.6× 32 0.6× 34 0.7× 42 1.3× 57 296
João Gregório Portugal 13 58 0.5× 47 0.7× 124 2.3× 19 0.4× 103 3.2× 57 493
Basil S. Karam United States 9 52 0.5× 46 0.7× 72 1.3× 59 1.2× 12 0.4× 26 1.4k

Countries citing papers authored by Michael A. Veronin

Since Specialization
Citations

This map shows the geographic impact of Michael A. Veronin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael A. Veronin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael A. Veronin more than expected).

Fields of papers citing papers by Michael A. Veronin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael A. Veronin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael A. Veronin. The network helps show where Michael A. Veronin may publish in the future.

Co-authorship network of co-authors of Michael A. Veronin

This figure shows the co-authorship network connecting the top 25 collaborators of Michael A. Veronin. A scholar is included among the top collaborators of Michael A. Veronin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael A. Veronin. Michael A. Veronin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Veronin, Michael A., et al.. (2024). A Framework for a New Paradigm of Opioid Drug Tapering Using Adjunct Drugs. PubMed. Volume 15. 197–207.
2.
Smith, Winter J., et al.. (2023). Pharmacy students’ perceptions and attitudes toward face-to-face vs. virtual team-based learning (TBL) in the didactic curriculum: A mixed-methods study. Medical Education Online. 28(1). 2226851–2226851. 9 indexed citations
3.
Veronin, Michael A., et al.. (2022). Evaluating the efficacy and safety of calcium channel blockers as adjunctive analgesics to opioid therapy: a literature review. Journal of Pharmacy Practice and Research. 52(1). 7–18. 5 indexed citations
4.
Mattison, Ryan J., et al.. (2021). Muscle relaxants as adjunctive analgesics in the perioperative setting: A review of the literature. Journal of Perioperative Practice. 33(3). 62–67. 2 indexed citations
5.
Veronin, Michael A., et al.. (2021). Dexmedetomidine as an adjunctive analgaesic in the perioperative setting: A review of the literature. Journal of Perioperative Practice. 31(6). 223–229. 3 indexed citations
6.
Veronin, Michael A., et al.. (2021). Carbamazepine, oxcarbazepine, and lacosamide as adjunctive analgesics: a review of the literature. Journal of Pharmacy Practice and Research. 51(1). 22–26.
7.
Schumaker, Robert P., et al.. (2021). A Data Driven Approach to Profile Potential SARS-CoV-2 Drug Interactions Using TylerADE. Journal of international technology and information management. 30(3). 108–142. 16 indexed citations
8.
Veronin, Michael A., et al.. (2020). A systematic approach to 'cleaning' of drug name records data in the FAERS database: a case report. 1(2). 105–105. 21 indexed citations
9.
Veronin, Michael A., et al.. (2020). Remdesivir and Coronavirus Disease 2019 (COVID-19): Essential Questions and Answers for Pharmacists and Pharmacy Technicians. Journal of Pharmacy Technology. 37(1). 62–74. 9 indexed citations
10.
Schumaker, Robert P., et al.. (2020). A systematic approach to 'cleaning' of drug name records data in the FAERS database: a case report. 1(2). 105–105. 1 indexed citations
11.
12.
West, Courtney, et al.. (2015). Tools to investigate how interprofessional education activities link to competencies. Medical Education Online. 20(1). 28627–28627. 15 indexed citations
13.
Veronin, Michael A., et al.. (2013). Attrition of Canadian Internet pharmacy websites: what are the implications?. Drug Healthcare and Patient Safety. 5. 171–171. 4 indexed citations
14.
Veronin, Michael A.. (2011). Should we have concerns with generic versus brand antimicrobial drugs? A review of issues. Journal of Pharmaceutical Health Services Research. 2(3). 135–150. 16 indexed citations
15.
Veronin, Michael A.. (2011). Packaging and Labeling of Pharmaceutical Products Obtained from the Internet. Journal of Medical Internet Research. 13(1). e22–e22. 20 indexed citations
16.
Veronin, Michael A., et al.. (2008). Comparison of Simvastatin Tablets from the US and International Markets Obtained via the Internet. Annals of Pharmacotherapy. 42(5). 613–620. 18 indexed citations
17.
Lou, Jennie Q., et al.. (2007). Technology and Health Care. NSUWorks (Nova Southeastern University). 305. 1 indexed citations
18.
Veronin, Michael A.. (2003). ‘URL 404 File Not Found’: dealing with the transient nature of the Web. Journal of Audiovisual Media in Medicine. 26(4). 153–155. 2 indexed citations
19.
Veronin, Michael A.. (2002). Where Are They Now? A Case Study of Health-related Web Site Attrition. Journal of Medical Internet Research. 4(2). e10–e10. 35 indexed citations
20.
Veronin, Michael A. & Gilbert Ramı́rez. (2000). The Validity of Health Claims on the World Wide Web: A Systematic Survey of the Herbal Remedy Opuntia. American Journal of Health Promotion. 15(1). 21–28. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by András Fittler Breakdown of academic impact, for papers by Amit Garg Breakdown of academic impact, for papers by Siti Maisharah Sheikh Ghadzi Breakdown of academic impact, for papers by Marie A. Abate Breakdown of academic impact, for papers by Hana Sulieman Breakdown of academic impact, for papers by Min Tan Breakdown of academic impact, for papers by Feliciano Yu Breakdown of academic impact, for papers by Dennis B. Worthen Breakdown of academic impact, for papers by João Gregório Breakdown of academic impact, for papers by Basil S. Karam
Rankless by CCL
2026